1. Home
  2. GLAS vs ASMB Comparison

GLAS vs ASMB Comparison

Compare GLAS & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glass House Brands Inc. Subordinate Voting Shares

GLAS

Glass House Brands Inc. Subordinate Voting Shares

N/A

Current Price

$2.37

Market Cap

504.2M

Sector

Health Care

ML Signal

N/A

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$19.61

Market Cap

512.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLAS
ASMB
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
504.2M
512.1M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
GLAS
ASMB
Price
$2.37
$19.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$9.00
★ $52.00
AVG Volume (30 Days)
★ 2.5M
186.2K
Earning Date
11-16-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 91.78
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.93
N/A
Revenue Next Year
$21.01
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$19.30
52 Week High
$12.70
$39.71

Technical Indicators

Market Signals
Indicator
GLAS
ASMB
Relative Strength Index (RSI) 22.56 33.39
Support Level $1.67 $19.30
Resistance Level $10.53 $30.36
Average True Range (ATR) 0.39 0.96
MACD 0.12 0.23
Stochastic Oscillator 33.91 12.69

Price Performance

Historical Comparison
GLAS
ASMB

About GLAS Glass House Brands Inc. Subordinate Voting Shares

Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Share on Social Networks: